The go t is closing in on the short and distort schemes, of

New Post Public Reply Private Reply Replies (1) Message Board
Dloggold
The go t is closing in on the short and distort schemes, of which treaty is a victim:


Elgindy was involved with NSOL (which later went through some ticker changes to become USFF, and is now revoked).....

funny thing was when I first came onto the (then) NSOL board years after Elgindy and was highly critical of the Co's pseudo-science junk-tech, some people claimed I was Elgindy posting from jail!!!!

(BTW, "Doctor" Paul Brown supposedly once made an anti-gravity device, or some such nonsense, although that was not the "tech" the Co was peddling, AFAIK)

ELGINDY and NSOL

http://www.elitetrader.com/et/index.php?threa...762/page-3

How The Govt Says Elgindy's Scheme Worked

By Michael Rapoport

NEW YORK (Dow Jones)--It was an audacious scheme, in prosecutors' telling: Use moles within the Federal Bureau of Investigation to get secret government information that could be damaging to a company, and then use that information to profit by short-selling the company's stock or by extorting the company outright.

That's what the government alleges Anthony Elgindy did, in an indictment released Wednesday. And while prosecutors are holding back on some of the details, the indictment does lay out a series of facts that can be pieced together into one detailed example of how the alleged scheme worked.

The information involves Nuclear Solutions Inc. (NSOL), a radioactive-waste treatment company which the government says Elgindy shorted last December - borrowing the company's shares and selling them in the hopes that the stock price would go down so that Elgindy could repurchase the shares at a lower price to return them to their owner, thereby making him a profit.

From the government's indictment, here's a chronology of what prosecutors say Elgindy did on Nuclear Solutions, matched with what was going on with the stock at the time:

Dec. 19: Jeffrey A. Royer, an FBI agent working with Elgindy and who was indicted along with him, searches the FBI's National Crime Information Center database and finds "criminal history information" about Paul Maurice Brown, the founder of Nuclear Solutions. (The government doesn't detail the nature of the information Royer found regarding Brown, who died in April. A Nuclear Solutions spokesman couldn't be reached for comment; Elgindy's attorneys also have not been available.)

Same day, about two hours later: Elgindy sends an e-mail to subscribers who follow his stock picks. The e-mail states: "NSOL - CEO, Dr. Paul Maurice Brown, is a convicted felon..."

That day, Nuclear Solutions stock tumbles from $3.20 a share to $2.45, on heavier-than-usual volume - a drop of about 23%.

Dec. 20: Elgindy and others begin posting information about Brown's alleged criminal record on Internet bulletin board and in chat rooms. In the indictment, the government alleges that Elgindy and his associates "sought to accomplish their manipulation by coordinating the release of negative information with short-selling in a manner designed to exaggerate the negative market sentiment for the stock."

Dec. 22 and 26: More negative e-mails from Elgindy about Nuclear Solutions. In one, he says that "Convicted Felon Brown ... has history of lying & fraud..." In aother, he says, "NSOL - info on (a Nuclear Solutions executive) the scumbag (attorney) ... has been disbarred..."

Dec. 24 on: Elgindy or his associates short Nuclear Solutions stock on seven separate occasions, lasting through most of January.

Dec. 27: Elgindy sends another e-mail to subscribers asking for details about their positions if they're short. Another e-mail, on Jan. 3, says "NSOL - short 20% @ 2.05 (add)." The "2.05" corresponds approximately to Nuclear Solutions' stock price at the time - a price which dwindles lower throughout most of January.

Jan. 30: In a chat-room discussion with his subscribers, Elgindy says that "We are pulling out of NSOL" and "NSOL <-- coverage (terminated) for good."

Jan. 31 and Feb. 1: Trading volume once again surges on Nuclear Solutions - consistent with the idea that any investors who had shorted the stock on the basis of Elgindy's e-mails were now repurchasing the stock to cover their positions. The price is volatile, plunging as low as $1 and going as high as $1.80.

The stock closes on Feb. 1 at $1.55. That's less than half the $3.20 a share it traded at before Elgindy's initial e-mail - a difference that represents profit to anyone who shorted the stock.



Treaty Energy Corporation (TECO) Stock Research Links

TECO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AppLovin Faces Lawsuit: Investor Unrest Unfolds

Updated Category News Views 5

Shaky Ground Beneath AppLovin's Feet Ah, the sweet smell of litigation in the tech space—it’s like déjà vu for seasoned market folks. Here we have AppLovin, nestled comfortably in San Francisco, now eying a saucy class-action lawsuit. We're looking at shareholders taking a firm stance against some arguably misleading claims. We're talking big deals with allegations...

Continue Reading
ACLM and eClinicalWorks Expand Lifestyle Medicine Reach

Updated Category News Views 74

Changing the Game with Lifestyle Medicine When it comes to healthcare, you're always going to have the skeptics grousing about the old ways. But what happens when you take an old idea and turbocharge it with modern tech? That's where the American College of Lifestyle Medicine (ACLM) and eClinicalWorks step in. They’re throwing a new wrench into the electronic health...

Continue Reading
ZBS Group Takes Over Rabinowitz’s CPA Practice with Bold Moves

Updated Category News Views 25

Transitioning Power in the CPA World Let's cut to the chase—when a seasoned CPA like Joseph Rabinowitz picks up the phone to secure a succession partner, it's a big deal. Enter ZBS Group LLP, steered by Michael Zaidman, which isn't a stranger to these waters, undertaking their fourth CPA practice acquisition through Rabinowitz's corner of the accounting universe....

Continue Reading
SWFI's I20 Summit Spotlights 3,000 Promising Start-Ups

Updated Category News Views 42

Spotlight on Emerging Titans: The Future 100 Watchlist The Sovereign Wealth Fund Institute is rattling the investment cages with their latest stunt, the 'Future 100 Watchlist.' Hot off the press, this list is parading nearly 3,000 start-ups that are biting at the heels of future success. It's high stakes and higher hopes between December 11-16 at Miami's I20 Summit, where...

Continue Reading
Artprice Bridges Art and AI Across the Hispanic World

Updated Category News Views 11

A Monumental Launch with Deep Roots I've been around long enough to see all sorts of moves in the art world and the tech world. But what Artprice by Artmarket is pulling off here—it’s a doozy. Thierry Ehrmann’s “Diálogo entre un pensador y la IA” just went live in Spanish, and that’s not some paperback thrill ride. We’re talking about an 1,800-page piece of...

Continue Reading
Tulsa Hosts Gradient's Global Tech and Investment Event

Updated Category News Views 21

Tulsa's New Spotlight: Gradient's CHROMA Event Well, look at Tulsa, becoming the center of the tech and enterprise universe for a day. Gradient is throwing open the doors for its second annual CHROMA event on September 24, 2026. You might scratch your head and say, ‘Tulsa? Really?’ But hear me out—this isn’t just a local shindig. We're talking about a one-day...

Continue Reading
SOPHiA GENETICS' Q3 2026: Revenue Growth & Challenges

Updated Category News Views 7

Unpacking SOPHiA GENETICS' Third Quarter Figures Let's cut through the jargon and get straight to the brass tacks. SOPHiA GENETICS (NASDAQ:SOPH) just posted their third quarter numbers for 2026, and it’s a mixed bag, my friends. Sure, they boasted a 25% bump in revenue, hitting $24.3 million, but the devil's in the details—net losses nudged up to $20.3 million, not...

Continue Reading
Marathon Petroleum's Massive Q3 2026 Profit Surge

Updated Category News Views 13

Marathon's Profit Skyrockets Marathon Petroleum Corp. (NYSE: MPC) just pulled off a Houdini act in the third quarter of 2026, as they reported a staggering net income of $7.4 billion. Compare that to last year's third quarter profits of $1.4 billion, and it's like comparing a sumo wrestler with a featherweight fighter. This transformation isn't just a fluke, it's a result...

Continue Reading
Newcomers, Veterans Elevate NYSE's Tokenization Efforts

Updated Category News Views 89

Breaking New Ground at the NYSE When the bell rings at the NYSE these days, it's not just marking the start of another trading session. It's the sound of change clanging its way onto Wall Street. On November 3, 2026, the NYSE threw its hat deeper into the tokenization ring, a game-changer perhaps. They've roped in some big guns—Securitize, tZERO, Broadridge Financial...

Continue Reading
Illumina's Role in Singapore's Precision Medicine Leap

Updated Category News Views 160

Singapore's Bold Step into Precision Medicine When it comes to revolutionizing healthcare, Singapore isn't content to sit on the sidelines. They've just thrown a serious hat into the ring with the SG-INSIGHT study, a cornerstone of their National Precision Medicine programme. And Illumina, Inc. (NASDAQ:ILMN) is right there in it, gearing up to sequence the genomes of...

Continue Reading

Top 5 Most Recently Viewed Articles

Rising Demand and Technological Advancements in Krill Meal Market

Updated Category News Views 226

Understanding the Expanding Krill Meal Market The krill meal market is undergoing remarkable growth, fueled by a shift in consumer preferences favoring clean-label food products and natural flavor enhancers. According to recent estimates, the market is poised to expand significantly, reaching an impressive valuation by the end of an upcoming decade. This growth can be...

Continue Reading
Tango Therapeutics Begins Dosing in Pivotal Cancer Trial

Updated Category News Views 224

Tango Therapeutics Begins Dosing in Pivotal Cancer Trial BOSTON — Tango Therapeutics, Inc. (NASDAQ: TNGX), a dynamic biotechnology company dedicated to revolutionizing cancer care, has achieved a pivotal milestone by dosing the first patient in its TNG456 Phase 1/2 trial aimed at patients with MTAP-deleted solid tumors, particularly glioblastoma (GBM). Known for its...

Continue Reading
Investors Invited to Explore Class Action against Rentokil Initial

Updated Category News Views 188

Investors Encouraged to Join Class Action Against Rentokil Initial Bronstein, Gewirtz & Grossman, LLC, a well-respected law firm known for its expertise in securities cases, is reaching out to investors of Rentokil Initial Plc. This communication centers around a class action lawsuit that has been filed on behalf of those affected by some significant events concerning the...

Continue Reading
Murphy USA's Dividend Boost: A Commitment to Shareholders

Updated Category News Views 78

Murphy USA's Dividend Boost Reflects Confidence in Growth Murphy USA Inc. (NYSE: MUSA), a well-known player in the gasoline and convenience store sector, has recently announced an increase in its quarterly cash dividend. The company's Board has declared a new dividend of $0.48 per share, which represents a notable 6.7% rise from the previous dividend. This increase...

Continue Reading
Cloudinary Enhances Digital Asset Management with New Features

Updated Category News Views 181

Cloudinary's Innovative Update to Digital Asset Management Today, Cloudinary, the leading image and video platform, revealed significant advancements in its API-first digital asset management (DAM) solution. These enhancements are designed to address the evolving needs of brands in managing their visual assets efficiently and effectively. With a focus on streamlining...

Continue Reading